Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia DOI Creative Commons
Ilona den Hartog, Laura B. Zwep,

Jacqueline J. Meulman

и другие.

Metabolomics, Год журнала: 2024, Номер 20(2)

Опубликована: Март 5, 2024

Abstract Introduction Longitudinal biomarkers in patients with community-acquired pneumonia (CAP) may help monitoring of disease progression and treatment response. The metabolic host response could be a potential source such since it closely associates the current health status patient. Objectives In this study we performed longitudinal metabolite profiling CAP for comprehensive range metabolites to identify biomarkers. Methods Previously collected serum samples from confirmed Streptococcus pneumoniae infection (n = 25) were used. Samples at multiple time points, up 30 days after admission. A wide was measured, including amines, acylcarnitines, organic acids, lipids. associations between C-reactive protein (CRP), procalcitonin, CURB severity score admission, total length stay evaluated. Results Distinct profiles identified, cholesteryl esters, diacyl-phosphatidylethanolamine, diacylglycerols, lysophosphatidylcholines, sphingomyelin, triglycerides. Positive correlations found CRP phosphatidylcholine (34:1) (cor 0.63) negative nine lysophosphocholines − 0.57 0.74). negatively associated six metabolites, acylcarnitines (tau 0.64 0.58). Negative triglycerides (TGs), especially TGs (60:3) (58:2) 0.63 0.61). Conclusion identified provide insight into biological mechanisms underlying interest exploration as biomarker.

Язык: Английский

TheMarker: a comprehensive database of therapeutic biomarkers DOI Creative Commons
Yintao Zhang, Ying Zhou, Yuan Zhou

и другие.

Nucleic Acids Research, Год журнала: 2023, Номер 52(D1), С. D1450 - D1464

Опубликована: Окт. 18, 2023

Abstract Distinct from the traditional diagnostic/prognostic biomarker (adopted as indicator of disease state/process), therapeutic (ThMAR) has emerged to be very crucial in clinical development and practice all therapies. There are five types ThMAR that have been found play indispensable roles various stages drug discovery, such as: Pharmacodynamic Biomarker essential for guaranteeing pharmacological effects a therapy, Safety critical assessing extent or likelihood therapy-induced toxicity, Monitoring guiding management by serially measuring patients’ status, Predictive maximizing outcome therapy specific individuals, Surrogate Endpoint fundamental accelerating approval therapy. However, these data ThMARs not comprehensively described any existing databases. Herein, database, named ‘TheMarker’, was therefore constructed (a) systematically offer used at different development, (b) describe information largest number drugs among available databases, (c) extensively cover widest classes just focusing on anticancer These TheMarker expected great implication significant impact discovery practice, it is freely accessible without login requirement at: https://idrblab.org/themarker.

Язык: Английский

Процитировано

40

Model-informed precision dosing: State of the art and future perspectives DOI Creative Commons
Iris K. Minichmayr, Erwin Dreesen, Marco Centanni

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2024, Номер 215, С. 115421 - 115421

Опубликована: Авг. 17, 2024

Model-informed precision dosing (MIPD) stands as a significant development in personalized medicine to tailor drug individual patient characteristics. MIPD moves beyond traditional therapeutic monitoring (TDM) by integrating mathematical predictions of dosing, and considering patient-specific factors (patient characteristics, measurements) well different sources variability. For this purpose, rigorous model qualification is required for the application patients. This review delves into new methods selection validation, also highlighting role machine learning improving MIPD, utilization biosensors real-time monitoring, potential models biomarkers efficacy or toxicity dosing. The clinical evidence TDM discussed various medical fields including infection medicine, oncology, transplant inflammatory bowel diseases, thereby underscoring pharmacokinetics/pharmacodynamics specific biomarkers. Further research, particularly randomized trials, warranted corroborate value enhancing outcomes advancing medicine.

Язык: Английский

Процитировано

16

Design principles of collateral sensitivity-based dosing strategies DOI Creative Commons
Linda B. S. Aulin, Apostolos Liakopoulos, Piet H. van der Graaf

и другие.

Nature Communications, Год журнала: 2021, Номер 12(1)

Опубликована: Сен. 28, 2021

Collateral sensitivity (CS)-based antibiotic treatments, where increased resistance to one leads a second antibiotic, may have the potential limit emergence of antimicrobial resistance. However, it remains unclear how best design CS-based treatment schedules. To address this problem, we use mathematical modelling study effects pathogen- and drug-specific characteristics for different designs on bacterial population dynamics evolution. We confirm that simultaneous one-day cycling treatments could supress in presence CS. show efficacy therapies depends critically order drug administration. Finally, find reciprocal CS is not essential suppress resistance, result significantly broadens options given ubiquity one-way pathogens. Overall, our analyses identify key principles strategies provide guidance develop schedules

Язык: Английский

Процитировано

43

Long-term antibacterial and biofilm dispersion activity of an injectable in situ crosslinked co-delivery hydrogel/microgel for treatment of implant infection DOI
Hao Cheng, Haibing Liu, Zhe Shi

и другие.

Chemical Engineering Journal, Год журнала: 2022, Номер 433, С. 134451 - 134451

Опубликована: Янв. 4, 2022

Язык: Английский

Процитировано

32

Immunosenescence and Inflamm-Aging: Clinical Interventions and the Potential for Reversal of Aging DOI Open Access

Samayak J Kumar,

Samarth Shukla,

Sunil Kumar

и другие.

Cureus, Год журнала: 2024, Номер unknown

Опубликована: Янв. 31, 2024

Inflammation is often associated with the impairment of ability to sustain consequences physical, chemical, nutritional, and antigenic triggers inflammation. The process immunosenescence may only partially be explained by senescence cells, tissues, or organism, and, hence, hallmarks markedly differentially affected history an individual's pathogenic encounter. a key component immunosenescence, which itself direct consequence aging. This review article highlights therapeutic interventions for slowing processes inflamm-aging possible reversal aging includes domains immunomodulatory interventions, vaccination strategies, nutritional stem cell therapies, personalized medicine, microbiome positive effects physical activity exercise.

Язык: Английский

Процитировано

7

Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review DOI Creative Commons
Maria Sanz-Codina, Markus Zeitlinger

Clinical Pharmacokinetics, Год журнала: 2022, Номер 61(5), С. 593 - 617

Опубликована: Фев. 25, 2022

The pathophysiology of sepsis alters drug pharmacokinetics, resulting in inadequate exposure and target-site concentration. Suboptimal leads to treatment failure the development antimicrobial resistance. Therefore, we seek optimize therapy by selecting right correct dosage. A prerequisite for achieving this goal is characterization understanding mechanisms pharmacokinetic alterations. However, most infections take place not blood but different body compartments. Since tissue assessment feasible daily practice, need tailor antibiotic according specific patient's pathophysiological processes. complex ineffectiveness current targeted therapies suggest that treatments guided biomarkers predicting concentration could provide a new therapeutic strategy. Inflammation, endothelial coagulation activation markers, flow parameters might be indicators impaired distribution. Moreover, hepatic renal dysfunction can predict only metabolism clearance also Identification direct dosing timely feedback on its effectiveness. decrease resistance mortality critically ill patients. This article fills literature gap characterizing patient used unbound plasma-to-tissue distribution Although all must clinically evaluated with ultimate combining them scoring system, support concept appropriate dosing.

Язык: Английский

Процитировано

25

Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection DOI Creative Commons
Qingze Gu, Jia Wei, Chang Ho Yoon

и другие.

Journal of Infection, Год журнала: 2024, Номер 88(5), С. 106156 - 106156

Опубликована: Апрель 8, 2024

To identify patterns in inflammatory marker and vital sign responses adult with suspected bloodstream infection (BSI) define expected trends normal recovery.

Язык: Английский

Процитировано

6

EXPAR for Biosensing: Recent Developments and Applications DOI Creative Commons

Xinyi Ou,

Kuilin Li,

Miao Liu

и другие.

The Analyst, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

Emerging as a promising novel amplification technique, the exponential reaction (EXPAR) offers significant advantages due to its potent capability, straightforward design, rapid kinetics, and isothermal operation. The past few years have witnessed swift advancements refinements in EXPAR-based technologies, with numerous high-performance biosensing systems documented. A deeper understanding of EXPAR mechanism has facilitated proposal strategies overcome limitations inherent traditional EXPAR. Furthermore, synergistic integration diverse methodologies, including use CRISPR/Cas system, metal nanoparticles, aptamers, alternative techniques, enzymes, significantly bolstered analytical efficacy, aiming enhance specificity, sensitivity, efficiency. This comprehensive review presents detailed exposition analyzes primary challenges. Additionally, we summarize latest research biomedical field concerning technologies for sensing strategies. Finally, discuss challenges future prospects technology realms clinical applications.

Язык: Английский

Процитировано

5

The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review DOI Creative Commons
Letao Li,

Julia Zinger,

Sebastiaan D. T. Sassen

и другие.

Critical Care, Год журнала: 2024, Номер 28(1)

Опубликована: Ноя. 19, 2024

Abstract Background The level of inflammation alters drug pharmacokinetics (PK) in critically ill patients. This might compromise treatment efficacy. Understanding the specific effects inflammation, measured by biomarkers, on absorption, distribution, metabolism, and excretion is help optimizing dosing strategies. Objectives review investigates relationship between inflammatory biomarkers PK parameters metabolism (ADME) patients, providing insight complexity drugs Method Following PRISMA guidelines, we conducted a comprehensive search Medline, Embase, Web Science, Cochrane databases (January 1946–November 2023). Studies examining parameters, or exposure patients were included. Records screened title, abstract, full text, with any discrepancies resolved through discussion consultation third reviewer. Results Of 4479 records screened, 31 met our inclusion criteria: 2 7 17 6 excretion. In general, results are only available for limited number drugs, most studies done looking at one components ADME. Higher levels may increase decrease absorption depending whether undergoes hepatic first-pass elimination. For negatively correlated protein binding capacity, positively cerebrospinal fluid penetration, peritoneal penetration. Metabolizing capacity was inversely biomarkers. Regarding excretion, can lead to reduced clearance, except neonatal population. Conclusion Inflammatory offer valuable information regarding altered Our findings emphasize need consider inflammation-driven variability when individualizing therapy this setting, same time research certain needs further research, also including pharmacodynamics.

Язык: Английский

Процитировано

5

Bladder Draining Methods DOI Creative Commons
D. D. Lukashev,

T. G. Mikhailikov,

P. A. Yartsev

и другие.

Russian Sklifosovsky Journal Emergency Medical Care, Год журнала: 2025, Номер 13(4), С. 684 - 690

Опубликована: Янв. 28, 2025

ABSTRACT The article provides a historical review of the literature describing evolution bladder drainage and types urinary catheters currently in use. Complications various methods are classified described, measures for their prevention proposed. AIM OF STUDY To study draining methods, advantages disadvantages, possible complications each method. OBJECTIVES assess indications use method, to focus attention health workers on possibility choosing optimal method draining, depending clinical situation.

Язык: Английский

Процитировано

0